Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00643175 · ClinicalTrials.gov registry record

Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture

A clinical trial, sponsored by State University of New York - Upstate Medical University.

Terminated
Registry status
20
Enrollment target

NCT00643175: Clinical Trial study, sponsored by State University of New York - Upstate Medical University.

NCT00643175 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00643175 was terminated before completion, sponsored by State University of New York - Upstate Medical University.

TERMINATED
Registry status
20 participants
Enrollment target

Study Summary

Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studies have shown that prior fracture increases the risk for further fracture. In 2004 the Surgeon General released a report on osteoporosis, the details of which include multi-disciplinary treatment of osteoporotic fractures. Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Possible planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.

Interventions

  • BEHAVIORAL Automated follow up

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-06
Est. Completion 2009-01

Why NCT00643175 stopped before completion

NCT00643175 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Automated follow up is the first listed.

NCT00643175 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00643175 about?

NCT00643175 is a clinical study titled "Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture". Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studi...

What is the current status of trial NCT00643175?

This trial is currently terminated. The enrollment target is 20 participants. The study started on 2007-06. Estimated completion is 2009-01.

What interventions are being tested in trial NCT00643175?

The interventions under investigation include: Automated follow up (BEHAVIORAL).

Who is sponsoring clinical trial NCT00643175?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00643175, the US trial registry maintained by the National Library of Medicine. NCT00643175 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.